Literature DB >> 30337176

Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update.

Kevin D Forsyth1, Tina Tan2, Carl-Heinz Wirsing von König3, Ulrich Heininger4, Amar J Chitkara5, Stanley Plotkin6.   

Abstract

Pertussis is a vaccine-preventable disease that causes morbidity and mortality, particularly in infants and children <5 years of age. The Global Pertussis Initiative (GPI) recommendations represent a systematic evaluation and prioritization of strategies to prevent pertussis-related infant and child deaths, reduce global disease burden and prevent resurgence through vaccination strategies and public health policies at national, regional and local levels. The GPI recommendations are based on clinical trials and observational and surveillance data, which are essential in the planning, implementation and evaluation of vaccination practices and best use of available resources. Many low- and middle-income countries (LMIC) continue to use whole-cell pertussis (wP) vaccines for primary vaccination, while most high-income countries have replaced wP with the less-reactogenic acellular pertussis (aP) vaccines. This present manuscript pertains to discussions held during the GPI's meeting on November 11-13, 2016, in Cape Town, Republic of South Africa. The GPI recommends that LMIC aim for high coverage of infant series pertussis vaccines as a priority. In LMIC and countries with constrained vaccine funding, if wP vaccines are currently used, wP should continue to be used. Furthermore, given that protection against disease and death due to pertussis in neonates is a key priority of the GPI, it recommends that ap immunization in pregnancy should be implemented as a priority in all countries if resources allow. Given that surveillance and epidemiology data on which to base vaccine decisions are important, the GPI also suggests that, in areas where wP vaccines are implemented, standardization and calibration of wP vaccines are checked, considering the many different manufacturers and variable standards of production and quality control. In addition, as immunity to pertussis wanes following the primary infant series of vaccination, the GPI further recommends that toddlers, adolescents, healthcare and childcare workers receive booster vaccine doses, where resources allow.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Epidemiology; Global Pertussis Initiative; Pertussis; Recommendations; Surveillance

Mesh:

Substances:

Year:  2018        PMID: 30337176     DOI: 10.1016/j.vaccine.2018.10.028

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context.

Authors:  Francesco Blasi; Paolo Bonanni; Fulvio Braido; Giovanni Gabutti; Federico Marchetti; Stefano Centanni
Journal:  Hum Vaccin Immunother       Date:  2019-09-06       Impact factor: 3.452

2.  Pertussis outbreak investigation in Janamora district, Amhara Regional State, Ethiopia: a case-control study.

Authors:  Lezhialem Almaw; Hailemichael Bizuneh
Journal:  Pan Afr Med J       Date:  2019-10-01

3.  Nasopharyngeal microbiota in hospitalized children with Bordetella pertussis and Rhinovirus infection.

Authors:  F Del Chierico; E Pandolfi; A E Tozzi; S Reddel; F Gesualdo; S Gardini; V Guarrasi; L Russo; I Croci; I Campagna; G Linardos; C Concato; A Villani; L Putignani
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

4.  A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.

Authors:  Kulkanya Chokephaibulkit; Thanyawee Puthanakit; Niranjan Bhat; Souad Mansouri; Yuxiao Tang; Keswadee Lapphra; Supattra Rungmaitree; Suvaporn Anugulruengkitt; Watsamon Jantarabenjakul; Indah Andi-Lolo; Renee Holt; Librada Fortuna; Chawanee Kerdsomboon; Pailinrut Chinwangso; Ladda Suwitruengrit; Anita H J van den Biggelaar; Simonetta Viviani; Hong Thai Pham; Bruce L Innis
Journal:  Vaccine       Date:  2021-11-14       Impact factor: 3.641

Review 5.  Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Asia.

Authors:  Denis Macina; Keith E Evans
Journal:  Infect Dis Ther       Date:  2021-04-29

6.  Pertussis-like illness is not the same as pertussis.

Authors:  Ulrich Heininger
Journal:  J Pediatr (Rio J)       Date:  2021-02-25       Impact factor: 2.990

7.  Association of Diphtheria-Tetanus-Acellular Pertussis Vaccine Timeliness and Number of Doses With Age-Specific Pertussis Risk in Infants and Young Children.

Authors:  Madhura S Rane; Pejman Rohani; M Elizabeth Halloran
Journal:  JAMA Netw Open       Date:  2021-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.